Correction to: Involvement of Complement in Alzheimer's Disease: From Genetics Through Pathology to Therapeutic Strategies [0.03%]
Correction to：阿尔茨海默病补体系统遗传、病理和治疗策略的研究进展
Nikoleta Daskoulidou,Sarah M Carpanini,Wioleta M Zelek et al.
Nikoleta Daskoulidou et al.
Published Erratum
Current topics in behavioral neurosciences. 2025 Jan 24. DOI:10.1007/7854_2024_576 2025
Cannabinoid-based Pharmacology for the Management of Substance Use Disorders [0.03%]
基于大麻素的药理学在物质使用障碍管理中的应用
M Á Luján,Y Kim,L Y Zhang et al.
M Á Luján et al.
In the last two decades, the endocannabinoid system has emerged as a crucial modulator of motivation and emotional processing. Due to its widespread neuroanatomical distribution and characteristic retrograde signaling nature, cannabinoid ty...
Using Inhibitory Learning Theories to Optimise Treatment for Children with Anxiety Disorders [0.03%]
运用抑制性学习理论优化儿童焦虑障碍的治疗
Wenting Chen,Melissa Aji,Chloe Y S Lim et al.
Wenting Chen et al.
Anxiety disorders in children lead to substantial impairment in functioning and development. Even the most effective gold standard treatments for childhood anxiety have 50% remission rates, suggesting a critical need to improve current trea...
Guruism and Cultic Social Dynamics in Psychedelic Practices and Organisations [0.03%]
致幻剂实践和组织中的 guru 主义与邪教社会动态
Jules Evans,Joseph Holcomb Adams
Jules Evans
This chapter explores the risks of guruism and cultic social dynamics in organisations that work with psychedelic drugs, which include therapist offices, clinics, research departments, retreat centres, training programmes, NGOs, underground...
Annaleah Hanske,Marc Nazaré,Uwe Grether
Annaleah Hanske
Cannabis sativa has been used therapeutically since early civilizations, with key cannabinoids Δ9-tetrahydrocannabinol (THC) 3.1 and cannabidiol characterized in the 1960s, leading to the discovery of cannabinoid receptors type 1 (CB1R) an...
Hippocampal Synaptic Plasticity: Integrating Memory and Anxiety Impairments in the Early Stages of Alzheimer's Disease [0.03%]
阿尔茨海默病早期阶段海马区突触可塑性整合记忆和焦虑损害
Mark A Good,David M Bannerman
Mark A Good
A decline in hippocampal function has long been associated with the progression of cognitive impairments in patients with Alzheimer's disease (AD). The disruption of hippocampal synaptic plasticity [primarily the reduction of long-term pote...
Current State of the Neuroscience of Fear Extinction and Its Relevance to Anxiety Disorders [0.03%]
恐惧消退的神经科学现状及其在焦虑障碍中的相关性
Elena Andres,Benjamin Meyer,Kenneth S L Yuen et al.
Elena Andres et al.
The elucidation of the functional neuroanatomy of human fear, or threat, extinction has started in the 2000s by a series of enthusiastically greeted functional magnetic resonance imaging (fMRI) studies that were able to translate findings f...
Mazdak M Bradberry,Paul S Appelbaum,Natalie Gukasyan
Mazdak M Bradberry
Humans have long used classical serotonergic psychedelics, such as psilocybin, for a variety of purposes. Entactogens, such as methylenedioxymethamphetamine (MDMA), emerged during the twentieth century and have likewise seen use in a broad ...
Phenomenology of Psychedelic Experiences and Psychedelic-Associated Distressing Effects: Quantifying Subjective Experiences [0.03%]
经典致幻剂所诱发的主观体验的量化研究
Cyril Costines,Timo Torsten Schmidt
Cyril Costines
The range of phenomena that can be induced by psychedelic substances is broad and variable, including effects on perception, cognition, and emotion. The umbrella term "psychedelic phenomenology" is used to refer to a combination of altered ...
Natalia Szejko,Kamila Saramak,Kirsten R Müller-Vahl
Natalia Szejko
Cannabis-based medicine (CBM) is used in a wide variety of different neurological disorders. While the use of CBM in the treatment of pain, AIDS wasting, loss of appetite, and spasticity is well established, CBM application in movement diso...